Literature DB >> 23852336

FGF23 and mineral metabolism in the early post-renal transplantation period.

Katherine Wesseling-Perry1, Renata C Pereira, Eileen Tsai, Robert Ettenger, Harald Jüppner, Isidro B Salusky.   

Abstract

BACKGROUND: The relationship between fibroblast growth factor 23 (FGF23) and vitamin D production and catabolism post-renal transplantation has not been characterized.
METHODS: Circulating creatinine, calcium, phosphorus, albumin, parathyroid hormone, FGF23, and 1,25(OH)2 vitamin D (calcitriol) values were obtained pre-transplantation, daily post-operatively for 5 days, and at 6 months post-transplantation in 44 patients aged 16.4 ± 0.4 years undergoing renal transplantation at UCLA from 1 August 2005 through to 30 April 2007. 25(OH) Vitamin D and 24,25(OH)2 vitamin D concentrations were obtained at baseline and on post-operative days 5 and 180, and urinary concentrations of creatinine, phosphorus, and FGF23 were measured on post-operative days 1, 3, 5, and 180.
RESULTS: Circulating phosphate concentrations declined more rapidly and the fractional excretion of phosphorus was higher in the first week post-transplantation in subjects with higher FGF23 values. Fractional excretion of FGF23 was low at all time-points. Circulating 1,25(OH)2 vitamin D levels rose more rapidly and were consistently higher in patients with lower FGF23 values; however, 25(OH) vitamin D and 24,25(OH)2 vitamin D values were unrelated to FGF23 concentrations.
CONCLUSIONS: Inhibition of renal 1α-hydroxylase, rather than stimulation of 24-hydroxylase, may primarily contribute to the relationship between FGF23 values and calcitriol. The rapid decline in FGF23 levels post-transplantation in our patient cohort was not mediated solely by the filtration of intact FGF23 by the new kidney.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23852336      PMCID: PMC3796035          DOI: 10.1007/s00467-013-2547-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  30 in total

1.  Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?

Authors:  I Bhan; A Shah; J Holmes; T Isakova; O Gutierrez; S M Burnett; H Jüppner; M Wolf
Journal:  Kidney Int       Date:  2006-08-30       Impact factor: 10.612

2.  Phosphate kinetics during hemodialysis: Evidence for biphasic regulation.

Authors:  Elaine M Spalding; Paul W Chamney; Ken Farrington
Journal:  Kidney Int       Date:  2002-02       Impact factor: 10.612

3.  Neural degeneration and regeneration in human renal transplants.

Authors:  A F Gazdar; G J Dammin
Journal:  N Engl J Med       Date:  1970-07-30       Impact factor: 91.245

4.  Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.

Authors:  A I Sánchez Fructuoso; M L Maestro; N Calvo; V De La Orden; I Pérez Flores; M Vidaurreta; R Valero; C Fernández-Pérez; A Barrientos
Journal:  Transplant Proc       Date:  2012-11       Impact factor: 1.066

5.  Aluminum metabolism and bone histology after kidney transplantation: a one-year follow-up study.

Authors:  K P Nordal; E Dahl; J Halse; L Aksnes; Y Thomassen; A Flatmark
Journal:  J Clin Endocrinol Metab       Date:  1992-05       Impact factor: 5.958

6.  FGF-23 and sFRP-4 in chronic kidney disease and post-renal transplantation.

Authors:  Sangeeta Pande; Cynthia S Ritter; Marcos Rothstein; Karen Wiesen; John Vassiliadis; Rajiv Kumar; Susan C Schiavi; Eduardo Slatapolsky; Alex J Brown
Journal:  Nephron Physiol       Date:  2006-05-10

7.  Sequential changes of biochemical bone parameters after kidney transplantation.

Authors:  W Reinhardt; H Bartelworth; F Jockenhövel; H Schmidt-Gayk; O Witzke; K Wagner; U W Heemann; D Reinwein; T Philipp; K Mann
Journal:  Nephrol Dial Transplant       Date:  1998-02       Impact factor: 5.992

8.  Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.

Authors:  Orlando Gutierrez; Tamara Isakova; Eugene Rhee; Anand Shah; Julie Holmes; Gina Collerone; Harald Jüppner; Myles Wolf
Journal:  J Am Soc Nephrol       Date:  2005-05-25       Impact factor: 10.121

9.  Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

Authors:  Shohei Nakanishi; Junichiro James Kazama; Tomoko Nii-Kono; Kentaro Omori; Takeyoshi Yamashita; Seiji Fukumoto; Fumitake Gejyo; Takashi Shigematsu; Masafumi Fukagawa
Journal:  Kidney Int       Date:  2005-03       Impact factor: 10.612

10.  Changes in plasma 1,25 and 24,25-dihydroxyvitamin D after renal transplantation in children.

Authors:  M Garabedian; C Silve; D Levy-Bentolila; A Bourdeau; A Ulmann; T M Nguyen; M Lieberherr; M Broyer; S Balsan
Journal:  Kidney Int       Date:  1981-09       Impact factor: 10.612

View more
  13 in total

1.  Membrane and integrative nuclear fibroblastic growth factor receptor (FGFR) regulation of FGF-23.

Authors:  Xiaobin Han; Zhousheng Xiao; L Darryl Quarles
Journal:  J Biol Chem       Date:  2015-03-09       Impact factor: 5.157

Review 2.  The Kidney-Vascular-Bone Axis in the Chronic Kidney Disease-Mineral Bone Disorder.

Authors:  Michael E Seifert; Keith A Hruska
Journal:  Transplantation       Date:  2016-03       Impact factor: 4.939

Review 3.  CYP3A4 is a crosslink between vitamin D and calcineurin inhibitors in solid organ transplant recipients: implications for bone health.

Authors:  A Prytuła; K Cransberg; A Raes
Journal:  Pharmacogenomics J       Date:  2017-04-18       Impact factor: 3.550

4.  Mineral metabolism in European children living with a renal transplant: a European society for paediatric nephrology/european renal association-European dialysis and transplant association registry study.

Authors:  Marjolein Bonthuis; Marco Busutti; Karlijn J van Stralen; Kitty J Jager; Sergey Baiko; Sevcan Bakkaloğlu; Nina Battelino; Maria Gaydarova; Bruno Gianoglio; Paloma Parvex; Clara Gomes; James G Heaf; Ludmila Podracka; Dafina Kuzmanovska; Maria S Molchanova; Tatiana E Pankratenko; Fotios Papachristou; György Reusz; Maria José Sanahuja; Rukshana Shroff; Jaap W Groothoff; Franz Schaefer; Enrico Verrina
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-20       Impact factor: 8.237

5.  Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness.

Authors:  David E Leaf; Kirolos A Jacob; Anand Srivastava; Margaret E Chen; Marta Christov; Harald Jüppner; Venkata S Sabbisetti; Aline Martin; Myles Wolf; Sushrut S Waikar
Journal:  J Am Soc Nephrol       Date:  2016-12-27       Impact factor: 10.121

Review 6.  The use of fibroblast growth factor 23 testing in patients with kidney disease.

Authors:  Edward R Smith
Journal:  Clin J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 8.237

Review 7.  Phosphate and FGF-23 homeostasis after kidney transplantation.

Authors:  Leandro C Baia; Ita Pfeferman Heilberg; Gerjan Navis; Martin H de Borst
Journal:  Nat Rev Nephrol       Date:  2015-09-29       Impact factor: 28.314

8.  CKD-MBD post kidney transplantation.

Authors:  Dieter Haffner; Maren Leifheit-Nestler
Journal:  Pediatr Nephrol       Date:  2019-12-19       Impact factor: 3.714

9.  Body mass index is associated with hyperparathyroidism in pediatric kidney transplant recipients.

Authors:  Karen Vanderstraeten; Rani De Pauw; Noël Knops; Antonia Bouts; Karlien Cransberg; Amina El Amouri; Ann Raes; Agnieszka Prytuła
Journal:  Pediatr Nephrol       Date:  2020-10-09       Impact factor: 3.714

Review 10.  Drug-metabolizing enzymes CYP3A as a link between tacrolimus and vitamin D in renal transplant recipients: is it relevant in clinical practice?

Authors:  Agnieszka Prytuła; Karlien Cransberg; Ann Raes
Journal:  Pediatr Nephrol       Date:  2018-07-30       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.